AstraZeneca gets EU backing for targeted breast cancer therapies

AstraZeneca gets EU backing for targeted breast cancer therapies
By

Breast cancer patients may now benefit from two of AstraZeneca's existing therapies. The EU has recommended lynparza and enhertu to treat high-risk breast cancer.





June 27, 2022 at 11:06PM
via FOX News : Health read more...